• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . SARS-CoV-2 variants evolve convergent strategies to remodel the host response

tetano

Editor, Senior Moderator
Cell


. 2023 Sep 19;S0092-8674(23)00915-7.
doi: 10.1016/j.cell.2023.08.026. Online ahead of print. SARS-CoV-2 variants evolve convergent strategies to remodel the host response

Mehdi Bouhaddou[SUP] 1 [/SUP], Ann-Kathrin Reuschl[SUP] 2 [/SUP], Benjamin J Polacco[SUP] 3 [/SUP], Lucy G Thorne[SUP] 2 [/SUP], Manisha R Ummadi[SUP] 3 [/SUP], Chengjin Ye[SUP] 4 [/SUP], Romel Rosales[SUP] 5 [/SUP], Adrian Pelin[SUP] 3 [/SUP], Jyoti Batra[SUP] 3 [/SUP], Gwendolyn M Jang[SUP] 3 [/SUP], Jiewei Xu[SUP] 3 [/SUP], Jack M Moen[SUP] 3 [/SUP], Alicia L Richards[SUP] 3 [/SUP], Yuan Zhou[SUP] 3 [/SUP], Bhavya Harjai[SUP] 3 [/SUP], Erica Stevenson[SUP] 3 [/SUP], Ajda Rojc[SUP] 3 [/SUP], Roberta Ragazzini[SUP] 6 [/SUP], Matthew V X Whelan[SUP] 7 [/SUP], Wilhelm Furnon[SUP] 8 [/SUP], Giuditta De Lorenzo[SUP] 8 [/SUP], Vanessa Cowton[SUP] 8 [/SUP], Abdullah M Syed[SUP] 9 [/SUP], Alison Ciling[SUP] 9 [/SUP], Noa Deutsch[SUP] 10 [/SUP], Daniel Pirak[SUP] 11 [/SUP], Giulia Dowgier[SUP] 12 [/SUP], Dejan Mesner[SUP] 7 [/SUP], Jane L Turner[SUP] 7 [/SUP], Briana L McGovern[SUP] 13 [/SUP], M Luis Rodriguez[SUP] 13 [/SUP], Rocio Leiva-Rebollo[SUP] 5 [/SUP], Alistair S Dunham[SUP] 14 [/SUP], Xiaofang Zhong[SUP] 3 [/SUP], Manon Eckhardt[SUP] 3 [/SUP], Andrea Fossati[SUP] 3 [/SUP], Nicholas F Liotta[SUP] 15 [/SUP], Thomas Kehrer[SUP] 16 [/SUP], Anastasija Cupic[SUP] 16 [/SUP], Magdalena Rutkowska[SUP] 16 [/SUP], Ignacio Mena[SUP] 5 [/SUP], Sadaf Aslam[SUP] 5 [/SUP], Alyssa Hoffert[SUP] 3 [/SUP], Helene Foussard[SUP] 3 [/SUP], Charles Ochieng' Olwal[SUP] 17 [/SUP], Weiqing Huang[SUP] 18 [/SUP], Thomas Zwaka[SUP] 18 [/SUP], John Pham[SUP] 19 [/SUP], Molly Lyons[SUP] 19 [/SUP], Laura Donohue[SUP] 19 [/SUP], Aliesha Griffin[SUP] 19 [/SUP], Rebecca Nugent[SUP] 19 [/SUP], Kevin Holden[SUP] 19 [/SUP], Robert Deans[SUP] 19 [/SUP], Pablo Aviles[SUP] 20 [/SUP], Jose A Lopez-Martin[SUP] 20 [/SUP], Jose M Jimeno[SUP] 20 [/SUP], Kirsten Obernier[SUP] 3 [/SUP], Jacqueline M Fabius[SUP] 3 [/SUP], Margaret Soucheray[SUP] 3 [/SUP], Ruth Hüttenhain[SUP] 3 [/SUP], Irwin Jungreis[SUP] 21 [/SUP], Manolis Kellis[SUP] 21 [/SUP], Ignacia Echeverria[SUP] 22 [/SUP], Kliment Verba[SUP] 22 [/SUP], Paola Bonfanti[SUP] 6 [/SUP], Pedro Beltrao[SUP] 23 [/SUP], Roded Sharan[SUP] 10 [/SUP], Jennifer A Doudna[SUP] 24 [/SUP], Luis Martinez-Sobrido[SUP] 4 [/SUP], Arvind H Patel[SUP] 8 [/SUP], Massimo Palmarini[SUP] 8 [/SUP], Lisa Miorin[SUP] 5 [/SUP], Kris White[SUP] 5 [/SUP], Danielle L Swaney[SUP] 3 [/SUP], Adolfo Garcia-Sastre[SUP] 25 [/SUP], Clare Jolly[SUP] 26 [/SUP], Lorena Zuliani-Alvarez[SUP] 27 [/SUP], Greg J Towers[SUP] 28 [/SUP], Nevan J Krogan[SUP] 29 [/SUP]



Affiliations
Abstract

SARS-CoV-2 variants of concern (VOCs) emerged during the COVID-19 pandemic. Here, we used unbiased systems approaches to study the host-selective forces driving VOC evolution. We discovered that VOCs evolved convergent strategies to remodel the host by modulating viral RNA and protein levels, altering viral and host protein phosphorylation, and rewiring virus-host protein-protein interactions. Integrative computational analyses revealed that although Alpha, Beta, Gamma, and Delta ultimately converged to suppress interferon-stimulated genes (ISGs), Omicron BA.1 did not. ISG suppression correlated with the expression of viral innate immune antagonist proteins, including Orf6, N, and Orf9b, which we mapped to specific mutations. Later Omicron subvariants BA.4 and BA.5 more potently suppressed innate immunity than early subvariant BA.1, which correlated with Orf6 levels, although muted in BA.4 by a mutation that disrupts the Orf6-nuclear pore interaction. Our findings suggest that SARS-CoV-2 convergent evolution overcame human adaptive and innate immune barriers, laying the groundwork to tackle future pandemics.

Keywords: SARS-CoV-2; innate immunity; protein-protein interactions; proteomics; systems biology; transcriptomics; variants; virus-host interactions.

 
Back
Top Bottom